PatientsVille.com Logo

PARANOIA and Amitriptyline

PatientsVille

PARANOIA Symptoms and Causes

Alzheimer's disease (AD) is the most common form of dementia among older people. Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities.

AD begins slowly. It first involves the parts of the brain that control thought, memory and language. People with AD may have trouble remembering things that happened recently or names of people they know. A related problem, mild cognitive impairment (MCI), causes more memory problems than normal for people of the same age. Many, but not all, people with MCI will develop AD.

In AD, over time, symptoms get worse. People may not recognize family members. They may have trouble speaking, reading or writing. They may forget how to brush their teeth or comb their hair. Later on, they may become anxious or aggressive, or wander away from home. Eventually, they need total care. This can cause great stress for family members who must care for them.

AD usually begins after age 60. The risk goes up as you get older. Your risk is also higher if a family member has had the disease.

No treatment can stop the disease. However, some drugs may help keep symptoms from getting worse for a limited time.

NIH: National Institute on Aging

Check out the latest treatments for PARANOIA

PARANOIA treatment research studies

Amitriptyline clinical trials, surveys and public health registries


Find Drug Side Effect reports



Amitriptyline Side Effects

Completed Suicide (98)
Toxicity To Various Agents (72)
Overdose (61)
Cardiac Arrest (57)
Somnolence (48)
Pain (47)
Convulsion (45)
Anxiety (44)
Headache (44)
Death (42)
Confusional State (40)
Vomiting (40)
Dizziness (39)
Intentional Overdose (39)
Dyspnoea (38)
Loss Of Consciousness (38)
Nausea (35)
Fatigue (35)
Coma (33)
Respiratory Arrest (33)
Depression (32)
Hypotension (31)
Agitation (31)
Hallucination (29)
Malaise (29)
Fall (28)
Cardio-respiratory Arrest (28)
Syncope (27)
Diarrhoea (26)
Insomnia (26)
Tremor (26)
Pyrexia (25)
Grand Mal Convulsion (25)
Delirium (24)
Asthenia (24)
Abdominal Pain (23)
Feeling Abnormal (23)
Suicide Attempt (23)
Dysarthria (22)
Depressed Level Of Consciousness (21)
Constipation (21)
Deep Vein Thrombosis (21)
Electrocardiogram Qt Prolonged (21)
Serotonin Syndrome (21)
Palpitations (21)
Weight Decreased (20)
Gait Disturbance (20)
Dry Mouth (19)
Metabolic Acidosis (19)
Rash (19)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

im on amitriptyline 25mg,i have my xmas party this weekend and wanted to drink alchol. i wonder is it a good idea

After having been on elavil for 9 years, mostly at 100mg/night, I spent the last 6 months weaning off. Shortly after stopping amitriptyline I now have high blood pressure. Before stopping, and for years before starting, my usual pressure was 115/65,

Be safe !!

Been on amitrip 25mg at night for 8 nights now and have felt and look alot better. although i have diarrihea now and felt abit of nausea here and there . feel a tad tired throughout the day but i think for me the postives outweigh

Can amitriptyline can cause thrombocytopenia ?

Doc gave me 25mg to help me sleep after quitting the weed. not as good as zoplicone though

Does Amtriptyline help tinnitus. I'm taking it at a low dose for jaw problems and fibromyalgia. the 25 mg dose seems to make my tinnitus worse but my pain better. I don't know what to do?

For the past 18 mnths myfifteen year old takes Pizotifen for migraine.Even on low dose it hasvirtually seen off the migraine episodes and apart from initial tiredness for the first few weeks on it, we are not aware of an

Hey i took 500mg of amitriptyline and overdosed and almost Died.. Dont take that much

I don't suffer from paranoia but my best friend does and it effects our friendship constantly. she always thinks someone is out to get her, she doesn't trust anyone and is constantly depressed. whenever i try to lift her up she ge

After taking the medication for two weeks I experience a severe allergic reaction to the medication. My side effects were paranoia hallucinations, anxiety, delusions, and psychosis. Due to the medication I was diagnosed bipolar.

Anxiety, Paranoia, Arrythmia

Dissociated state, extreme fatigue, paranoia , anxiety , panic attacks,

I don't suffer from paranoia but my best friend does and it effects our friendship constantly. she always thinks someone is out to get her, she doesn't trust anyone and is constantly depressed. whenever i try to lift her up she ge

I have been taking Champix for a week now and all I have to report is that it is a bad thing to take with alcohol. I have only experienced depression and paranoia when drinking and have had no physical side affects at all. The way I look at it, it's

I have just been prescribed endone 5 Mg for chronic lower back painand told to take two every 4 hours which i did for 24 hrs , after 24 hrs i had a massive bout of paranoia hot and cold and soreness to some parts of my skin i have stopped t

I would be interested in hearing from other people if they experienced this side effect:paranoia from taking humira. donnah7002@aol.com THANKS.

Kept my paranoia to the minimum. but i am too depressd, and cant get off of it

Me too, kathy...surprising that no one else is mentioning this strange anxiety side effect. One would think that a good night's sleep would NOT result in needless paranoia.

Severe hallucinations and complete paranoia.

PARANOIA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Cognitive Behavioral Therapy for the Prevention of Paranoia in Adolescents at High Risk
Conditions: ARMS;   APS;   Prodromal Symptoms
Intervention: Behavioral: Cognitive Behavioral Therapy
Outcome Measures: Change in CAARMS from Baseline;   Change in Depressive Symptoms from Baseline;   Change in Anxiety Symptoms from Baseline;   Change in PDI Score from Baseline;   Change in Perceived Stress from Baseline;   Change in Role and Social Functioning from Baseline;   Change in Social Functioning from Baseline;   Change in Cognitive Biases from Baseline;   Change from Baseline in a Tendency to Jump to Conclusions;   Change in Family Member's Perceived Stress from Baseline;   Change in Perceived Family Member Empathy from Baseline
2 Not yet recruiting Computerised Interventions for Thinking and Anxiety in Delusions (CITADEL) Trial
Condition: Paranoia in People With Schizophrenia-spectrum Diagnosis
Interventions: Other: Anxiety intervention;   Other: Reasoning intervention
Outcome Measure: Green Paranoid Thoughts Scale
3 Recruiting Inpatient Evaluation of Adults With Schizophrenia
Conditions: Psychotic Disorder;   Schizophrenia;   Schizoaffective;   Paranoia;   Psychosis
Intervention:
Outcome Measure:
4 Recruiting Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers
Conditions: Healthy;   Mood Disorder;   Parkinson's Disease;   Schizophrenia
Intervention:
Outcome Measure:
5 Recruiting Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Intervention: Drug: Intranasal Oxytocin Spray
Outcome Measures: Change in social cognition scores from baseline to 6 and 12 week time points;   Change in social functioning measures from baseline to 6 and 12 week time points;   Change in PANSS total and subscale scores from baseline to 6 and 12 week time points.
6 Recruiting Genetic Study of Schizophrenia
Conditions: Psychotic Disorder;   Schizoaffective Disorder;   Schizophrenia
Intervention:
Outcome Measure:
7 Recruiting Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Condition: Smoking Cessation
Interventions: Drug: Placebo;   Drug: varenicline tartrate;   Drug: bupropion hydrochloride;   Drug: Nicotine Replacement Therapy Patch
Outcome Measures: At least 1 severe AE of anxiety depression, feeling abnormal, or hostility and/or moderate or severe AE of: agitation, aggression, delusions, hallucinations, homicidal ideation, mania, panic, Paranoia, psychosis, suicidal ideation/behavior/completed;   4 week Carbon Monoxide (CO) confirmed continuous abstinence for Weeks 9 through 12.;   Carbon Monoxide (CO) confirmed continuous abstinence from Week 9 through Week 24;   The presence or absence of each component comprising the primary neuropsychiatric adverse event endpoint.;   Individual item responses and overall scores for Hospital Anxiety and Depression Scale;   Individual item responses and overall scores for Columbia Suicide Severity Rating Scale;   Individual item responses and overall scores for Global Clinical Impression of Improvement
8 Recruiting A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis
Condition: Methamphetamine Dependence
Interventions: Drug: paliperidone;   Drug: Risperidone
Outcome Measures: The severity of psychosis;   Clinical general status
9 Recruiting Cross-Sectional Iloperidone IVGTT
Conditions: Schizophrenia;   Serious Mental Illness;   Metabolic Syndrome;   Insulin Resistance;   Glucose Metabolism
Intervention:
Outcome Measures: Difference between cohorts in glucose metabolism;   Difference between cohorts in triglycerides;   Difference between cohorts on LDL cholesterol
10 Not yet recruiting Minocycline Augmentation to Clozapine
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Minocycline;   Drug: Sugar Pill
Outcome Measures: Positive symptoms of schizophrenia/schizoaffective disorder;   Negative symptoms of schizophrenia/schizoaffective disorder;   Cognitive symptoms of schizophrenia/schizoaffective disorder;   Perceived quality of life and general well being;   Social, occupational, and psychological functioning;   Number of patients with adverse events;   Markers of inflammation, including C-Reactive Protein
11 Recruiting Lifestyle Intervention for Diabetes and Weight Management in Psychosis
Conditions: Type 2 Diabetes Mellitus;   Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder;   Bipolar I Disorder;   Major Depression With Psychotic Features;   Substance-induced Psychosis;   Psychosis Not Otherwise Specified
Interventions: Behavioral: Lifestyle Intervention;   Other: Usual Care
Outcome Measures: Weight;   HbA1c levels
12 Recruiting Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers
Condition: Cocaine-induced Psychotic Disorder During Intoxication
Interventions: Other: Interviews;   Other: Blood sample;   Other: Hair sample
Outcome Measures: causes and protective factors of Cocaine Induced Psychosis CIP;   gene, environment interactions associated with CIP
13 Not yet recruiting The Pharmaco-genetic and Brain Mechanisms Associated With Cannabis- Induced Psychosis
Conditions: Cannabis Dependence;   Psychosis
Intervention:
Outcome Measures: Genetic variations of Dopamine, GABA, glutamate, cannabis CB1 receptor;   Measures of dopamine D2 receptor occupancy before and after smoking a cigarette containing THC.